Company · CIK 1813814
Definium Therapeutics, Inc.
| CIK | 1813814 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2833 — Medicinal Chemicals & Botanical Products |
| Incorporated in | A1 |
| Business address | NY |
| Listed | DFTX (Nasdaq) |
| First annual or quarterly report | 2022-03-28 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-280548 | 2024-06-28 | 2026-06-24 | 7 | |
| 333-278468 | 2024-04-02 | 2024-04-29 | 2 | |
| 333-264648 | 2022-05-04 | 2024-03-08 | 5 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-24 | 424B5Shelf takedown | 333-280548 | 0001104659-26-077349 |
| 2026-06-22 | 424B5Shelf takedown | 333-280548 | 0001104659-26-076393 |
| 2025-10-31 | 424B5Shelf takedown | 333-280548 | 0001104659-25-104545 |
| 2025-10-29 | 424B5Shelf takedown | 333-280548 | 0001104659-25-103716 |
| 2024-08-12 | 424B5Shelf takedown | 333-280548 | 0001104659-24-088003 |
| 2024-08-09 | 424B5Shelf takedown | 333-280548 | 0001104659-24-087478 |
| 2024-06-28 | S-3ASRShelf registered | 333-280548 | 0001104659-24-076002 |
| 2024-04-29 | EFFECTDeclared effective | 333-278468 | 9999999995-24-001181 |
| 2024-04-02 | S-3Shelf registered | 333-278468 | 0001193125-24-084762 |
| 2024-03-08 | 424B5Shelf takedown | 333-264648 | 0001193125-24-062602 |
| 2022-09-29 | 424B5Shelf takedown | 333-264648 | 0001193125-22-254340 |
| 2022-09-27 | 424B5Shelf takedown | 333-264648 | 0001193125-22-252178 |
| 2022-05-16 | EFFECTDeclared effective | 333-264648 | 9999999995-22-001536 |
| 2022-05-04 | S-3Shelf registered | 333-264648 | 0001193125-22-138900 |
| 2021-04-12 | EFFECTDeclared effective | 333-254859 | 9999999995-21-001397 |